Prescription Drug Marketing Act

Indonesia Anti-Rheumatic Drug Market Analysis Report 2022: A $4.35 Billion Market by 2027 Featuring Pfizer, GlaxoSmithKline, & F. Hoffmann-La Roche - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Biotechnology, Infectious Diseases, Other Health, Health, Pharmaceutical, Rheumatology, Prescription drug, Energy, World Bank Group, Rheumatoid arthritis, Inflammatory bowel disease, World Health Organization, Prescription Drug Marketing Act, Incidence, Methotrexate, Inflammation, Sulfasalazine, Osteoarthritis, Prevalence, Ankylosing spondylitis, OTC, Malaria, Ageing, Pharmaceutical industry, Vaccine

The "Indonesia Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Indonesia Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Indonesia antirheumatic drugs market was valued at US$3,543.837 million in 2020.
  • The market is projected to grow at a CAGR of 3.00% to attain a value of US$4,359.458 million by 2027.
  • PT Kalbe Farma Tbk, is an Indonesian-based healthcare firm that develops OTC drugs, Prescription drugs, nutrition products, and energy drinks.

Iran Anti-Rheumatic Drug Market Analysis Report 2022: A $2+ Billion Market by 2027 Featuring GlaxoSmithKline, F. Hoffmann-La Roche, & Novartis - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Biotechnology, General Health, Health, Pharmaceutical, Physical Therapy, Joint, Rheumatoid arthritis, Investment, Arthropathy, World Health Organization, DSM-IV codes, Projection, Prescription Drug Marketing Act, Obesity, Nonsteroidal anti-inflammatory drug, Incidence, Gout, Lupus, Pain, Disease, CVD, Prevalence, OTC, Arthritis, Osteoarthritis, Pharmaceutical industry

The "Iran Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Iran Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Iran's antirheumatic drugs market was evaluated at US$1,645.313 million in the year 2020, growing at a CAGR of 3.16% reaching the market size of US$ 2,045.699 million by the year 2027.
  • Iran's antirheumatic drugs market has been segmented based on the type of disease, type of molecule, and sales channel.
  • By type of molecule, the Iran antirheumatic drugs market has been classified into pharmaceuticals and biopharmaceuticals.

China Anti-Rheumatic Drug Market Forecasts Report 2022: A $24.65 Billion Market by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Pharmaceutical, Health, Nursing, NMPA, Ankylosing spondylitis, Ulcerative colitis, Roche, Coronavirus, Rheumatoid arthritis, Investment, Tocilizumab, Prescription Drug Marketing Act, Osteoarthritis Research Society International, Patient, RA, Gout, Lupus, Growth, Infliximab, Adalimumab, Rheumatology, Prevalence, COVID-19, Psoriasis, National Health Commission, OTC, Arthritis, Osteoarthritis, Pharmaceutical industry, Disease-modifying antirheumatic drug

The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The market is projected to grow at a CAGR of 3.73% to attain a value of US$24.654 billion by 2027.
  • A growing number of patients suffering from arthritis in China is the major driver of the antirheumatic drugs market in the country.
  • As such, changing lifestyles will continue this trend during the next five years, thus positively impacting the market growth of antirheumatic drugs in China.

Global Direct-acting Antiviral Drug Market Report 2022-2027: Availability of Directly-Acting Antiviral Medicines Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 29, 2022
Health, Pharmaceutical, Online, Ansoff Matrix, Hospital pharmacy, Market share, SWOT, HIV, Prescription Drug Marketing Act, Route, USD, Protein, Porter's five forces analysis, Risk, Growth, Investment, COVID-19, NS5B, Intravenous therapy, Observation, Market development, Geography, Medical device, Vaccine, Retail, Risk management, Pharmaceutical industry

The Global Direct-acting Antiviral Drug Market is segmented based on Type, Indication, Route, Distribution Channel, and Geography.

Key Points: 
  • The Global Direct-acting Antiviral Drug Market is segmented based on Type, Indication, Route, Distribution Channel, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Direct-acting Antiviral Drug Market.
  • The analyst analyses the Global Direct-acting Antiviral Drug Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Direct-acting Antiviral Drug Market.

Gastrointestinal Drug Market Report 2022: Trends, Forecast and Competitive Analysis, 2016-2027 by Drug Class, Route of Administration, Application, Distribution Channel - ResearchAndMarkets.com

Retrieved on: 
Monday, August 15, 2022
Health, Pharmaceutical, Investment, Competitive analysis, GERD, Acid, Biliary reflux, Prescription Drug Marketing Act, Irritable bowel syndrome, Gastroesophageal reflux disease, Inflammatory bowel disease, Government, CAGR, R, Growth, Dietary supplement, Fine chemical

The "Gastrointestinal Drug Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gastrointestinal Drug Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The global gastrointestinal drug market is expected to grow with a CAGR of 4%-6% from 2022 to 2027.
  • The future of the gastrointestinal drug market looks promising with opportunities in the cure of gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome disorders/applications.
  • The study includes a forecast for the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region.

Global Direct-acting Antiviral Drug Market to Reach $4+ Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Health, General Health, COVID-19, USD, CAGR, NS5B, Compound annual growth rate, State, Prescription Drug Marketing Act, Vaccine, Cryptocurrency

The "Direct-acting Antiviral Drug Market Research Report by Type (NS3/4A Protease, NS5A Protein, and NS5B RNA-Dependent RNA polymerase), Indication, Route, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Direct-acting Antiviral Drug Market Research Report by Type (NS3/4A Protease, NS5A Protein, and NS5B RNA-Dependent RNA polymerase), Indication, Route, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The United States Direct-acting Antiviral Drug Market size was estimated at USD 1,676.39 million in 2021, USD 2,013.27 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 15.62% to reach USD 4,005.91 million by 2027.